MRSN MRSN
$29.08
+0.14%
at last close
Analyst Consensus
- Consensus Rating
- Hold (0 Buy · 3 Hold · 0 Sell)
- Average Price Target
- $30.75
- Implied Upside
- +5.7%
- Price Target Range
- $30.75 – $30.75
- Analysts (12 mo)
- 3
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2025-11-14 | GuggenheimMichael Schmitz |
Downgrades | Buy → Neutral | — |
| 2025-11-13 | Truist SecuritiesAsthika Goonewardene |
Downgrades | Buy → Hold | $36 → $31 |
| 2025-11-13 | BTIGJustin Zelin |
Downgrades | Buy → Neutral | — |
| 2025-08-14 | Truist SecuritiesAsthika Goonewardene |
Maintains | Buy | $250 → $36 |
| 2025-08-14 | GuggenheimMichael Schmidt |
Maintains | Buy | $125 → $30 |
| 2025-05-16 | Truist SecuritiesAsthika Goonewardene |
Maintains | Buy | $9 → $10 |
| 2025-05-16 | GuggenheimMichael Schmidt |
Reiterates | Buy | $5 |
| 2025-02-06 | William BlairAndy Hsieh |
Initiates coverage on | Outperform | — |
| 2024-08-27 | CitigroupAshiq Mubarack |
Maintains | Buy | $6 → $5 |
| 2024-08-14 | BairdColleen Kusy |
Maintains | Neutral | $4 → $3 |
| 2024-03-19 | JP MorganBrian Cheng |
Upgrades | Underweight → Neutral | $5 |
| 2024-02-29 | WedbushDavid Nierengarten |
Upgrades | Neutral → Outperform | $2 → $7 |
| 2024-02-29 | Truist SecuritiesAsthika Goonewardene |
Upgrades | Hold → Buy | $9 |
| 2024-02-29 | BairdColleen Kusy |
Maintains | Neutral | $1 → $5 |
| 2024-02-29 | GuggenheimMichael Schmidt |
Upgrades | Neutral → Buy | $7 |
| 2023-12-04 | CitigroupAshiq Mubarack |
Upgrades | Neutral → Buy | $1 → $5 |
| 2023-07-28 | CitigroupAshik Kurian |
Downgrades | Buy → Neutral | $10 → $1 |
| 2023-07-28 | BairdColleen Kusy |
Downgrades | Outperform → Neutral | $7 → $1 |
| 2023-07-27 | WedbushDavid Nierengarten |
Downgrades | Outperform → Neutral | $12 → $2 |
| 2023-07-27 | Truist SecuritiesAsthika Goonewardene |
Downgrades | Buy → Hold | — |
| 2023-06-16 | CitigroupAshik Kurian |
Maintains | Buy | $15 → $10 |
| 2023-06-16 | JP MorganBrian Cheng |
Downgrades | Overweight → Neutral | $11 → $5 |
| 2023-06-15 | GuggenheimMichael Schmidt |
Initiates coverage on | Buy | $14 |
| 2023-05-11 | CitigroupAshik Kurian |
Maintains | Buy | $12 → $15 |
| 2023-03-16 | JP MorganBrian Cheng |
Upgrades | Neutral → Overweight | $10 |
| 2022-11-21 | Truist SecuritiesAsthika Goonewardene |
Initiates coverage on | Buy | $12 |
| 2022-08-09 | BairdColleen Kusy |
Maintains | Outperform | $18 → $20 |
| 2022-08-09 | SVB LeerinkJonathan Chang |
Maintains | Outperform | $13 → $14 |
| 2022-05-09 | SVB LeerinkJonathan Chang |
Maintains | Outperform | $13 → $14 |
| 2022-02-18 | SVB LeerinkJonathan Chang |
Maintains | Outperform | $25 → $16 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $29.08
- Market Cap
- —
- 52-Week Range
- $5.21 – $30.39
- Average Volume
- 99K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.